Exposure to nanomaterials

We are improving the knowledge that protects workers and the public from the potentially harmful effects of nanomaterials whilst independently advising industry on safety practices.
Nanotechnology is a growing area of interest for businesses and governments, and investment is increasing. The use of nanomaterials in products offers advantages in terms of their performance. However, there is uncertainty on their potential adverse health effects. Researchers believe that the toxicity of nanomaterials seems to be higher than the toxicity of identical materials in larger particles.

The special features of nanomaterials provide challenges on the evaluation of their risk and many principles and routines applied to traditional chemicals do not work with nanomaterials. Understanding their hazards and exposures are important to assess the risk they pose for humans and the environment.

We have been a leading research institute in this field, our results inform policymakers and regulators whilst providing industry information on safe innovation approaches, and risk management measures to ensure a sustainable development for nanotechnology.

Our research:

Our research focuses on:

  • occupational and consumer exposure assessment (measurement & modelling)
  • hazard and toxicity assessment (laboratory testing & computational methods)
  • risk assessment and risk management
  • risk governance
  • databases 
We have provided independent expertise on the development of frameworks for the human health risk assessment of nanomaterials and have built an international research reputation in the field of nanosafety.

We are an invited expert on ISO Technical Committee 229 (Nanotechnologies) and are represented on OECD WPMN working groups and British Standards Institute committees, as well as being an active member of the EU-US nanoEHS Communities of Research and the EU Nano-Safety Cluster.

Key projects 

 

 

Sponsors we have worked for

  • European Commission
  • IOMworld Posted: 3 days ago
    New research gives clear advice for employers on managing musculoskeletal disorders (MSDs) in the workplace.… https://t.co/VAjBtjom6w
  • IOMworld Posted: 3 days ago
    We have published over 2,500 articles and major pieces of project work. Today we are one of Europe’s principal work… https://t.co/t5Gc07YYP5
  • IOMworld Posted: 4 days ago
    One in four of the population suffer from chronic musculoskeletal disorders (MSDs). Discover good practice advice o… https://t.co/ENeRWMBlHA
  • IOMworld Posted: 4 days ago
    Restrict the transmission of the #COVID19 virus in the workplace with a #COVID19 workplace risk assessment. Find ou… https://t.co/15jhgFZpkd
  • IOMworld Posted: 17 days ago
    Last chance to get involved the future of healthy working by taking part in the EPHOR survey and be part of ground… https://t.co/T8Y5M84RuC
  • IOMworld Posted: 20 days ago
    Use your expert knowledge and be a part of ground-breaking research on developing innovative methods for working-li… https://t.co/FGcuKD0qHF
  • IOMworld Posted: 22 days ago
    Find out how you can help to advance occupational health science in a unique way to reduce the burden of disease. C… https://t.co/70Vl3Qv1EL
  • IOMworld Posted: 24 days ago
    We have published over 2,500 articles and major pieces of project work. Today we are one of Europe’s principal work… https://t.co/C2daujZVK7
  • IOMworld Posted: 25 days ago
    #NanoTox2021 is taking place online from 20th – 22nd April 2021 ➡️Nanotechnology ➡️ Hazard and risk assessment of n… https://t.co/JC30t6iKhf
  • IOMworld Posted: 26 days ago
    Talking about the physical and emotional aspects of working from home & how it impacts both organisations & humans… https://t.co/OYw7dsIvHF